Southern Acids (M) Berhad Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Southern Acids (M) Berhad.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth	25.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Southern Acids (M) Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KLSE:SAB - Analysts future estimates and past financials data (MYR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	946	6	-14	23	N/A
3/31/2024	920	14	-6	28	N/A
12/31/2023	934	-1	-17	16	N/A
9/30/2023	977	11	61	93	N/A
6/30/2023	1,025	28	82	109	N/A
3/31/2023	1,107	33	85	111	N/A
12/31/2022	1,222	69	140	164	N/A
9/30/2022	1,253	80	77	98	N/A
6/30/2022	1,220	86	71	92	N/A
3/31/2022	1,181	94	65	85	N/A
12/31/2021	1,039	74	28	56	N/A
9/30/2021	918	53	25	49	N/A
6/30/2021	846	44	-3	21	N/A
3/31/2021	746	37	26	49	N/A
12/31/2020	704	40	18	31	N/A
9/30/2020	690	44	25	36	N/A
6/30/2020	682	44	45	61	N/A
3/31/2020	666	32	14	30	N/A
12/31/2019	627	24	18	54	N/A
9/30/2019	602	19	34	73	N/A
6/30/2019	588	19	18	54	N/A
3/31/2019	604	21	27	66	N/A
12/31/2018	658	29	29	60	N/A
9/30/2018	711	35	9	38	N/A
6/30/2018	747	32	9	39	N/A
3/31/2018	767	33	N/A	56	N/A
12/31/2017	787	41	N/A	56	N/A
9/30/2017	780	44	N/A	41	N/A
6/30/2017	752	47	N/A	44	N/A
3/31/2017	740	49	N/A	17	N/A
12/31/2016	646	37	N/A	-1	N/A
9/30/2016	579	29	N/A	7	N/A
6/30/2016	548	23	N/A	8	N/A
3/31/2016	503	25	N/A	29	N/A
12/31/2015	479	27	N/A	34	N/A
9/30/2015	490	30	N/A	54	N/A
6/30/2015	507	30	N/A	48	N/A
3/31/2015	537	28	N/A	45	N/A
12/31/2014	575	29	N/A	43	N/A
9/30/2014	585	31	N/A	30	N/A
6/30/2014	565	38	N/A	40	N/A
3/31/2014	544	38	N/A	36	N/A
12/31/2013	539	39	N/A	58	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SAB's forecast earnings growth is above the savings rate (3.6%).

Earnings vs Market: Insufficient data to determine if SAB's earnings are forecast to grow faster than the MY market

High Growth Earnings: Insufficient data to determine if SAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SAB's revenue is forecast to grow faster than the MY market.

High Growth Revenue: Insufficient data to determine if SAB's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SAB's Return on Equity is forecast to be high in 3 years time

Southern Acids (M) Berhad Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target decreased to RM3.40

Price target decreased to RM3.40

Price target decreased to RM3.40

Recent updates

New minor risk - Market cap size

Upcoming dividend of RM0.05 per share

New major risk - Revenue and earnings growth

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

New minor risk - Market cap size

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad (KLSE:SAB) entered into agreement to acquire remaining 10% stake in Firstview Development Sdn Bhd from Low Mong Hua Sdn Berhad for RM 23.5 million.

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

Upcoming dividend of RM0.05 per share at 1.5% yield

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

New minor risk - Market cap size

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Outhern Acids (M) Berhad Recommends Single Tier Final Dividend in Respect of the Financial Year Ended 31 March 2023

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Third quarter 2023 earnings released: EPS: RM0.12 (vs RM0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.082 (vs RM0.13 in 2Q 2022)

Price target decreased to RM3.40

Insufficient new directors

Upcoming dividend of RM0.05 per share

Full year 2022 earnings released: EPS: RM0.69 (vs RM0.27 in FY 2021)

Southern Acids (M) Berhad Announces Final Dividend, Payable on 28 Nov. 2022

Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to RM3.40

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2022 earnings released: EPS RM0.17 (vs RM0.13 in 1Q 2021)

Upcoming dividend of RM0.05 per share

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

Price target decreased to RM3.40

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

Southern Acids (M) Berhad Recommends Final Dividend for the Year Ended March 31, 2021

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Third quarter 2021 earnings released: EPS RM0.041 (vs RM0.076 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

New 90-day high: RM3.88

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

Second quarter 2021 earnings released: EPS RM0.06

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

New 90-day high: RM3.80

Southern Acids (M) Berhad Announces the Resignation of Encik Teo Leng as Independent and Non Executive Member of Audit Committee

New 90-day high: RM3.72

Upcoming Dividend of RM0.05 Per Share

First quarter earnings released

New 90-day high - RM3.68

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies